Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
34.00 EUR | -1.49% | +0.71% | +20.66% |
Sep. 13 | A central bank and it's off again? | |
Sep. 13 | JPMorgan Upgrades Fresenius to Overweight, Lifts PT | MT |
Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Revenues | 35.41B | 36.28B | 37.52B | 40.84B | 22.3B | |||||
Total Revenues | 35.41B | 36.28B | 37.52B | 40.84B | 22.3B | |||||
Cost of Goods Sold, Total | 25.06B | 26.19B | 27.26B | 30.12B | 17.24B | |||||
Gross Profit | 10.35B | 10.09B | 10.26B | 10.72B | 5.06B | |||||
Selling General & Admin Expenses, Total | 5.41B | 5.24B | 5.45B | 6.74B | 3.16B | |||||
R&D Expenses | 660M | 758M | 784M | 842M | 608M | |||||
Other Operating Expenses | -249M | -151M | 86M | -231M | 115M | |||||
Other Operating Expenses, Total | 5.82B | 5.84B | 6.32B | 7.36B | 3.88B | |||||
Operating Income | 4.53B | 4.24B | 3.94B | 3.37B | 1.18B | |||||
Interest Expense, Total | -881M | -752M | -630M | -694M | -534M | |||||
Interest And Investment Income | 162M | 93M | 124M | 187M | 118M | |||||
Net Interest Expenses | -719M | -659M | -506M | -507M | -416M | |||||
Income (Loss) On Equity Invest. | - | 94M | 93M | 68M | -12M | |||||
Currency Exchange Gains (Loss) | -18M | -72M | 87M | -28M | 16M | |||||
EBT, Excl. Unusual Items | 3.79B | 3.61B | 3.61B | 2.9B | 768M | |||||
Impairment of Goodwill | - | -195M | - | - | - | |||||
Gain (Loss) On Sale Of Investments | 74M | 46M | -56M | -91M | - | |||||
Gain (Loss) On Sale Of Assets | 29M | 31M | - | - | - | |||||
Asset Writedown | 15M | 7M | -21M | -25M | -53M | |||||
Other Unusual Items | - | 229M | 116M | 27M | - | |||||
EBT, Incl. Unusual Items | 3.91B | 3.73B | 3.65B | 2.81B | 715M | |||||
Income Tax Expense | 883M | 903M | 833M | 697M | 477M | |||||
Earnings From Continuing Operations | 3.03B | 2.82B | 2.82B | 2.12B | 238M | |||||
Earnings Of Discontinued Operations | - | - | - | - | -947M | |||||
Net Income to Company | 3.03B | 2.82B | 2.82B | 2.12B | -709M | |||||
Minority Interest | -1.15B | -1.12B | -1B | -745M | 115M | |||||
Net Income - (IS) | 1.88B | 1.71B | 1.82B | 1.37B | -594M | |||||
Net Income to Common Incl Extra Items | 1.88B | 1.71B | 1.82B | 1.37B | -594M | |||||
Net Income to Common Excl. Extra Items | 1.88B | 1.71B | 1.82B | 1.37B | 353M | |||||
Per Share Items | ||||||||||
Net EPS - Basic | 3.38 | 3.06 | 3.26 | 2.44 | -1.05 | |||||
Basic EPS - Continuing Operations | 3.38 | 3.06 | 3.26 | 2.44 | 0.63 | |||||
Basic Weighted Average Shares Outstanding | 557M | 557M | 558M | 561M | 563M | |||||
Net EPS - Diluted | 3.38 | 3.06 | 3.26 | 2.44 | -1.05 | |||||
Diluted EPS - Continuing Operations | 3.38 | 3.06 | 3.26 | 2.44 | 0.63 | |||||
Diluted Weighted Average Shares Outstanding | 557M | 558M | 558M | 561M | 563M | |||||
Normalized Basic EPS | 2.2 | 2.04 | 2.25 | 1.91 | 1.06 | |||||
Normalized Diluted EPS | 2.2 | 2.04 | 2.25 | 1.91 | 1.06 | |||||
Dividend Per Share | 0.84 | 0.88 | 0.92 | 0.92 | - | |||||
Payout Ratio | 23.63 | 27.42 | 27.01 | 64.87 | -92.59 | |||||
American Depositary Receipts Ratio (ADR) | 0.25 | 0.25 | 0.25 | 0.25 | 0.25 | |||||
Supplemental Items | ||||||||||
EBITDA | 5.98B | 5.94B | 5.51B | 5.07B | 1.79B | |||||
EBITA | 4.75B | 4.66B | 4.15B | 3.62B | 1.39B | |||||
EBIT | 4.53B | 4.24B | 3.94B | 3.37B | 1.18B | |||||
EBITDAR | 6.12B | 6.07B | 5.64B | 5.22B | 1.87B | |||||
Effective Tax Rate - (Ratio) | 22.57 | 24.24 | 22.81 | 24.77 | 66.71 | |||||
Current Domestic Taxes | 32M | 137M | 78M | 78M | 111M | |||||
Current Foreign Taxes | 782M | 723M | 671M | 744M | 381M | |||||
Total Current Taxes | 814M | 860M | 749M | 822M | 492M | |||||
Deferred Domestic Taxes | 76M | -12M | 19M | 69M | 59M | |||||
Deferred Foreign Taxes | -7M | 55M | 65M | -194M | -74M | |||||
Total Deferred Taxes | 69M | 43M | 84M | -125M | -15M | |||||
Normalized Net Income | 1.23B | 1.14B | 1.26B | 1.07B | 595M | |||||
Interest on Long-Term Debt | 217M | 205M | 188M | 202M | 61M | |||||
Non-Cash Pension Expense | 31M | 22M | 23M | 25M | 25M | |||||
Supplemental Operating Expense Items | ||||||||||
Selling and Marketing Expenses | 1.02B | 1.06B | 1.06B | 1.22B | 750M | |||||
General and Administrative Expenses | 4.39B | 4.18B | 4.39B | 5.52B | 2.4B | |||||
Research And Development Expense From Footnotes | 645M | 751M | 805M | 867M | 661M | |||||
Net Rental Expense, Total | 136M | 135M | 132M | 154M | 76M | |||||
Imputed Operating Lease Interest Expense | 41.46M | 30.55M | 25.07M | 31.14M | 14.9M | |||||
Imputed Operating Lease Depreciation | 94.54M | 104M | 107M | 123M | 61.1M | |||||
Stock-Based Comp., Other (Total) | 9.85M | -4.11M | 28M | -5M | 18M | |||||
Total Stock-Based Compensation | 9.85M | -4.11M | 28M | -5M | 18M |